HERTRAZ also known as Trastuzumab is an anticancer drug used for the treatment of HER2-positive breast cancer (around 25% of all breast cancer). Hertraz is also used to treat certain type of stomach cancer. It can be obtained only with prescription.
Manufacturer : Biocon Limited
Strengths available : 150mg & 440mg Vial
Dosage :
Hertraz should be administered as intravenous infusion.
Do not administer as an intravenous push or bolus.
Weekly Schedule: The recommended initial loading dose is 4 mg/kg body weight Hertraz administered as a 90-minute intravenous infusion. Patients should be observed for fever and chills or other infusion-associated symptoms. Interruption of the infusion may help control such symptoms. The infusion may be resumed when symptoms abate.
Subsequent Doses: The recommended weekly dose of Hertraz is 2 mg/kg body weight. If the prior dose was well tolerated, the dose can be administered as a 30-minute infusion.
Patients should be observed for fever and chills or other infusion-associated symptoms.
Most common side effects are Dizziness, fever or chills, headache, muscle aches, nausea or vomiting, skin rash, sore throat, stuffy or runny nose, unusual tiredness or weakness.
Pack of 1 Vial
Mehan Biosciences is a WHO GDSP approved & licensed Pharmaceutical stockist/wholesaler/distributor/exporter/importer of HERTRAZ Trastuzumab 150mg & 440mg based in India - To buy HERTRAZ Trastuzumab 150mg & 440mg or know its cost price contact us here.
We supply & sell HERTRAZ Trastuzumab 150mg & 440mg for Reference Listed Drugs, Government Tenders, Shortage Lists, Emergency Imports, Name Patient Drugs, Comparator Drug Studies, Un-licensed Importation, clinical trial samples & Bio-Similars.
At MBS, we acknowledge the critical role that reliable sourcing and timely delivery play in the healthcare industry. MBS is your trusted partner in pharmaceutical supply chain management.